Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 11 | 2025 | 139 | 5.100 |
Why?
|
| General Surgery | 18 | 2025 | 210 | 3.560 |
Why?
|
| Internship and Residency | 21 | 2025 | 803 | 2.880 |
Why?
|
| Colorectal Neoplasms | 9 | 2022 | 289 | 2.430 |
Why?
|
| Colectomy | 7 | 2025 | 123 | 2.350 |
Why?
|
| Surgeons | 9 | 2025 | 191 | 2.130 |
Why?
|
| Postoperative Complications | 16 | 2025 | 1334 | 2.070 |
Why?
|
| Fellowships and Scholarships | 7 | 2025 | 102 | 1.780 |
Why?
|
| Colorectal Surgery | 5 | 2025 | 51 | 1.570 |
Why?
|
| Faculty, Medical | 4 | 2025 | 200 | 1.550 |
Why?
|
| Education, Medical, Graduate | 15 | 2025 | 348 | 1.510 |
Why?
|
| Time-to-Treatment | 4 | 2021 | 133 | 1.480 |
Why?
|
| Hospitals, High-Volume | 5 | 2021 | 36 | 1.400 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 220 | 1.290 |
Why?
|
| Neoadjuvant Therapy | 4 | 2025 | 102 | 1.170 |
Why?
|
| Watchful Waiting | 2 | 2025 | 33 | 1.140 |
Why?
|
| Career Mobility | 3 | 2018 | 63 | 1.130 |
Why?
|
| New York | 11 | 2020 | 144 | 1.070 |
Why?
|
| Personnel Selection | 3 | 2025 | 56 | 1.060 |
Why?
|
| Rectum | 5 | 2025 | 97 | 1.060 |
Why?
|
| Gallbladder Diseases | 3 | 2016 | 26 | 1.030 |
Why?
|
| Male | 53 | 2025 | 31187 | 1.020 |
Why?
|
| Career Choice | 7 | 2025 | 127 | 1.020 |
Why?
|
| Minority Groups | 3 | 2023 | 142 | 1.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2016 | 49 | 1.010 |
Why?
|
| Mobile Applications | 3 | 2017 | 140 | 1.000 |
Why?
|
| Patient Readmission | 5 | 2025 | 452 | 0.960 |
Why?
|
| Surgical Stapling | 2 | 2024 | 11 | 0.950 |
Why?
|
| Quality Improvement | 5 | 2025 | 468 | 0.950 |
Why?
|
| Humans | 72 | 2025 | 65463 | 0.950 |
Why?
|
| Female | 53 | 2025 | 34193 | 0.920 |
Why?
|
| Anastomosis, Surgical | 2 | 2024 | 118 | 0.910 |
Why?
|
| Retrospective Studies | 24 | 2025 | 6929 | 0.910 |
Why?
|
| Correspondence as Topic | 1 | 2025 | 11 | 0.880 |
Why?
|
| Adenocarcinoma | 3 | 2025 | 367 | 0.870 |
Why?
|
| Middle Aged | 34 | 2025 | 18387 | 0.860 |
Why?
|
| Incisional Hernia | 1 | 2024 | 15 | 0.840 |
Why?
|
| Robotic Surgical Procedures | 4 | 2021 | 172 | 0.830 |
Why?
|
| Ileostomy | 3 | 2022 | 28 | 0.830 |
Why?
|
| Specialties, Surgical | 3 | 2025 | 46 | 0.810 |
Why?
|
| Patient Discharge | 3 | 2025 | 521 | 0.810 |
Why?
|
| Stress, Psychological | 2 | 2018 | 475 | 0.810 |
Why?
|
| Neoplasm Staging | 7 | 2025 | 552 | 0.780 |
Why?
|
| Aged | 29 | 2025 | 15052 | 0.760 |
Why?
|
| Lymphoma | 1 | 2023 | 101 | 0.750 |
Why?
|
| Schools, Medical | 3 | 2018 | 150 | 0.730 |
Why?
|
| Fecal Incontinence | 2 | 2025 | 33 | 0.720 |
Why?
|
| Clinical Competence | 11 | 2025 | 732 | 0.710 |
Why?
|
| Laparoscopy | 8 | 2024 | 492 | 0.710 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 628 | 0.710 |
Why?
|
| Travel | 2 | 2021 | 44 | 0.700 |
Why?
|
| Adult | 31 | 2025 | 17461 | 0.700 |
Why?
|
| Personnel Turnover | 2 | 2018 | 24 | 0.690 |
Why?
|
| Physicians, Women | 2 | 2025 | 43 | 0.690 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2021 | 33 | 0.680 |
Why?
|
| Quality of Life | 5 | 2025 | 1263 | 0.680 |
Why?
|
| Obesity, Morbid | 3 | 2018 | 94 | 0.680 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2025 | 377 | 0.670 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 150 | 0.660 |
Why?
|
| United States | 22 | 2025 | 8148 | 0.660 |
Why?
|
| Intestinal Obstruction | 2 | 2020 | 52 | 0.650 |
Why?
|
| Postoperative Period | 2 | 2017 | 130 | 0.630 |
Why?
|
| Treatment Outcome | 14 | 2025 | 5806 | 0.610 |
Why?
|
| Quality of Health Care | 2 | 2021 | 533 | 0.600 |
Why?
|
| Surveys and Questionnaires | 8 | 2021 | 2776 | 0.590 |
Why?
|
| Motivation | 2 | 2018 | 298 | 0.580 |
Why?
|
| Follow-Up Studies | 11 | 2025 | 2492 | 0.570 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 88 | 0.560 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 409 | 0.560 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 26 | 0.560 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 599 | 0.550 |
Why?
|
| Infliximab | 1 | 2018 | 50 | 0.550 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 76 | 0.530 |
Why?
|
| Time Out, Healthcare | 1 | 2017 | 1 | 0.530 |
Why?
|
| Physician's Role | 1 | 2018 | 122 | 0.520 |
Why?
|
| Colostomy | 1 | 2017 | 25 | 0.510 |
Why?
|
| Confidentiality | 1 | 2017 | 58 | 0.510 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 38 | 0.500 |
Why?
|
| Electric Stimulation Therapy | 1 | 2017 | 28 | 0.500 |
Why?
|
| Biological Products | 1 | 2018 | 93 | 0.500 |
Why?
|
| Surgery Department, Hospital | 1 | 2016 | 19 | 0.500 |
Why?
|
| Hepatectomy | 1 | 2017 | 63 | 0.500 |
Why?
|
| Cultural Diversity | 1 | 2017 | 54 | 0.490 |
Why?
|
| Racism | 1 | 2018 | 93 | 0.490 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 279 | 0.490 |
Why?
|
| Teaching Rounds | 1 | 2016 | 9 | 0.480 |
Why?
|
| Surgical Oncology | 2 | 2025 | 7 | 0.460 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2017 | 90 | 0.460 |
Why?
|
| Time Factors | 6 | 2025 | 3774 | 0.450 |
Why?
|
| Self Care | 1 | 2017 | 218 | 0.450 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2022 | 708 | 0.450 |
Why?
|
| Telemedicine | 2 | 2017 | 373 | 0.450 |
Why?
|
| Leadership | 1 | 2017 | 212 | 0.440 |
Why?
|
| Patient Participation | 1 | 2017 | 234 | 0.440 |
Why?
|
| Operating Rooms | 1 | 2015 | 60 | 0.430 |
Why?
|
| Palliative Care | 1 | 2017 | 250 | 0.420 |
Why?
|
| Students, Medical | 1 | 2017 | 265 | 0.420 |
Why?
|
| Stents | 2 | 2020 | 500 | 0.420 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 308 | 0.410 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 441 | 0.400 |
Why?
|
| Aged, 80 and over | 13 | 2025 | 5644 | 0.390 |
Why?
|
| Risk Assessment | 2 | 2016 | 2111 | 0.380 |
Why?
|
| Computer Simulation | 1 | 2015 | 485 | 0.370 |
Why?
|
| Patient Care Team | 1 | 2015 | 336 | 0.360 |
Why?
|
| Gastrectomy | 3 | 2018 | 39 | 0.360 |
Why?
|
| Colon | 3 | 2024 | 147 | 0.360 |
Why?
|
| Qualitative Research | 3 | 2025 | 757 | 0.350 |
Why?
|
| Logistic Models | 6 | 2021 | 1273 | 0.350 |
Why?
|
| Combined Modality Therapy | 3 | 2021 | 372 | 0.330 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 244 | 0.320 |
Why?
|
| Risk Factors | 6 | 2025 | 5458 | 0.320 |
Why?
|
| Anastomotic Leak | 2 | 2024 | 36 | 0.310 |
Why?
|
| Hospitalization | 2 | 2016 | 1399 | 0.310 |
Why?
|
| Length of Stay | 3 | 2025 | 828 | 0.300 |
Why?
|
| Grounded Theory | 2 | 2018 | 20 | 0.280 |
Why?
|
| Hospital Mortality | 4 | 2017 | 879 | 0.270 |
Why?
|
| Elective Surgical Procedures | 2 | 2025 | 120 | 0.260 |
Why?
|
| Databases, Factual | 4 | 2018 | 887 | 0.260 |
Why?
|
| Cohort Studies | 4 | 2018 | 2633 | 0.250 |
Why?
|
| Prospective Studies | 6 | 2022 | 3324 | 0.250 |
Why?
|
| Reoperation | 2 | 2018 | 307 | 0.240 |
Why?
|
| Digital Rectal Examination | 1 | 2025 | 3 | 0.240 |
Why?
|
| Propensity Score | 2 | 2025 | 192 | 0.240 |
Why?
|
| Neoplasm, Residual | 1 | 2025 | 52 | 0.230 |
Why?
|
| Constriction, Pathologic | 1 | 2025 | 131 | 0.220 |
Why?
|
| Social Support | 2 | 2018 | 393 | 0.220 |
Why?
|
| Prognosis | 4 | 2025 | 1789 | 0.220 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 128 | 0.220 |
Why?
|
| Diverticulitis, Colonic | 1 | 2024 | 38 | 0.210 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2023 | 1 | 0.200 |
Why?
|
| Academic Medical Centers | 4 | 2023 | 308 | 0.200 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 52 | 0.190 |
Why?
|
| Age Factors | 5 | 2018 | 1592 | 0.190 |
Why?
|
| School Admission Criteria | 1 | 2022 | 10 | 0.180 |
Why?
|
| Lymph Nodes | 1 | 2023 | 237 | 0.180 |
Why?
|
| Young Adult | 9 | 2019 | 4837 | 0.180 |
Why?
|
| Academic Failure | 2 | 2018 | 2 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 808 | 0.170 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2011 | 37 | 0.170 |
Why?
|
| Colonoscopy | 1 | 2021 | 97 | 0.170 |
Why?
|
| Aging | 2 | 2018 | 774 | 0.170 |
Why?
|
| Gastric Bypass | 2 | 2018 | 69 | 0.160 |
Why?
|
| Linear Models | 2 | 2018 | 405 | 0.160 |
Why?
|
| Weight Loss | 3 | 2018 | 275 | 0.160 |
Why?
|
| Educational Measurement | 2 | 2018 | 214 | 0.160 |
Why?
|
| Hospitals, Low-Volume | 2 | 2016 | 20 | 0.150 |
Why?
|
| Regional Health Planning | 1 | 2019 | 10 | 0.150 |
Why?
|
| Massachusetts | 1 | 2025 | 2153 | 0.140 |
Why?
|
| Models, Statistical | 2 | 2017 | 309 | 0.140 |
Why?
|
| Life Change Events | 1 | 2018 | 66 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2018 | 21 | 0.140 |
Why?
|
| Appendectomy | 1 | 2018 | 57 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 30 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2019 | 288 | 0.130 |
Why?
|
| Video-Assisted Surgery | 1 | 2017 | 8 | 0.130 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2017 | 6 | 0.130 |
Why?
|
| Fees and Charges | 1 | 2017 | 17 | 0.130 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 31 | 0.130 |
Why?
|
| Biliopancreatic Diversion | 1 | 2017 | 2 | 0.130 |
Why?
|
| Computer Security | 1 | 2017 | 16 | 0.130 |
Why?
|
| Appendicitis | 1 | 2018 | 84 | 0.130 |
Why?
|
| Standard of Care | 1 | 2017 | 29 | 0.130 |
Why?
|
| Duodenum | 1 | 2017 | 41 | 0.130 |
Why?
|
| Observer Variation | 1 | 2017 | 216 | 0.120 |
Why?
|
| Emergencies | 1 | 2017 | 124 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2017 | 589 | 0.120 |
Why?
|
| Device Removal | 1 | 2017 | 64 | 0.120 |
Why?
|
| Morbidity | 1 | 2016 | 110 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 56 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 34 | 0.120 |
Why?
|
| Comorbidity | 2 | 2017 | 1120 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2018 | 532 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 1231 | 0.120 |
Why?
|
| Income | 1 | 2017 | 169 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 682 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 57 | 0.120 |
Why?
|
| Educational Status | 1 | 2017 | 279 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 106 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 76 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 32 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 252 | 0.120 |
Why?
|
| Incidence | 4 | 2024 | 1430 | 0.120 |
Why?
|
| Anal Canal | 1 | 2016 | 38 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 529 | 0.110 |
Why?
|
| Adolescent | 5 | 2019 | 6332 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 97 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 126 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 804 | 0.110 |
Why?
|
| Anxiety | 1 | 2018 | 427 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 438 | 0.110 |
Why?
|
| Esophagus | 1 | 2014 | 47 | 0.110 |
Why?
|
| Cholecystitis, Acute | 1 | 2014 | 30 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 94 | 0.110 |
Why?
|
| Esophageal Achalasia | 1 | 2015 | 35 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 995 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2016 | 400 | 0.100 |
Why?
|
| Survival Rate | 3 | 2025 | 847 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 81 | 0.100 |
Why?
|
| Patient Safety | 1 | 2016 | 281 | 0.100 |
Why?
|
| Acute Disease | 1 | 2014 | 663 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2012 | 94 | 0.090 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2011 | 6 | 0.090 |
Why?
|
| Nose Neoplasms | 1 | 2011 | 17 | 0.090 |
Why?
|
| Global Health | 1 | 2012 | 181 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2011 | 66 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 616 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2011 | 67 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2019 | 1021 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 250 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 732 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 263 | 0.070 |
Why?
|
| Pregnancy | 1 | 2016 | 2390 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 354 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1564 | 0.060 |
Why?
|
| New York City | 2 | 2017 | 96 | 0.060 |
Why?
|
| Obesity | 1 | 2014 | 1275 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1284 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1161 | 0.050 |
Why?
|
| Sexism | 1 | 2023 | 31 | 0.050 |
Why?
|
| Recurrence | 1 | 2024 | 662 | 0.050 |
Why?
|
| Accreditation | 1 | 2022 | 76 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 75 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2017 | 899 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 755 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 529 | 0.030 |
Why?
|
| Feedback | 1 | 2017 | 91 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2018 | 93 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 101 | 0.030 |
Why?
|
| SEER Program | 1 | 2017 | 75 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2018 | 143 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 174 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 111 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 929 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 155 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 146 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 498 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 213 | 0.030 |
Why?
|
| Perineum | 1 | 2016 | 20 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 382 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 97 | 0.030 |
Why?
|
| Manometry | 1 | 2015 | 28 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2017 | 370 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 300 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 125 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 148 | 0.020 |
Why?
|
| Wound Healing | 1 | 2014 | 193 | 0.020 |
Why?
|
| International Educational Exchange | 1 | 2012 | 2 | 0.020 |
Why?
|
| Lymphatic Irradiation | 1 | 2011 | 2 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2011 | 9 | 0.020 |
Why?
|
| Stomatitis | 1 | 2011 | 8 | 0.020 |
Why?
|
| Radiodermatitis | 1 | 2011 | 11 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 88 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 27 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2721 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 45 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 64 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 42 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 208 | 0.020 |
Why?
|
| Depression | 1 | 2017 | 903 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 318 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 2666 | 0.020 |
Why?
|
| Child | 1 | 2011 | 4623 | 0.010 |
Why?
|